These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34958632)

  • 1. Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.
    Zhang Y; Dai J; Huang W; Chen Q; Chen W; He Q; Chen F; Zhang P
    Aging (Albany NY); 2021 Dec; 13(24):25980-26002. PubMed ID: 34958632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma.
    Yang K; Lu XF; Luo PC; Zhang J
    Biomed Res Int; 2018; 2018():9303486. PubMed ID: 30406146
    [No Abstract]   [Full Text] [Related]  

  • 3. A prognostic nomogram based on competing endogenous RNA network for clear-cell renal cell carcinoma.
    Peng Y; Wu S; Xu Z; Hou D; Li N; Zhang Z; Wang L; Wang H
    Cancer Med; 2021 Aug; 10(16):5499-5512. PubMed ID: 34196116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comprehensive analysis of the aberrantly expressed profiles of lncRNAs, miRNAs and the regulation network of the associated ceRNAs in clear cell renal cell carcinoma].
    Hou W; Tang Q; Bi F
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Apr; 36(2):267-273. PubMed ID: 31016944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis.
    Zhou L; Ye J; Wen F; Yu H
    Dis Markers; 2022; 2022():4033583. PubMed ID: 35320950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Long Noncoding RNAs (lncRNAs) in Clear Cell Kidney Carcinoma Revealed by Reconstruction and Comprehensive Analysis of the lncRNA-miRNA-mRNA Regulatory Network.
    Zhu H; Lu J; Zhao H; Chen Z; Cui Q; Lin Z; Wang X; Wang J; Dong H; Wang S; Tan J
    Med Sci Monit; 2018 Nov; 24():8250-8263. PubMed ID: 30444862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
    Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z
    Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.
    Ma W; Zhong M; Liu X
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
    Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y
    Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma.
    Zhang H; Ye Q; Chen Z; Zhao C; Wu Q; Ding Y; Shao Q; Zhao Y
    Dis Markers; 2022; 2022():8928282. PubMed ID: 36438902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
    Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
    Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ceRNA Network Composed of Survival-Related lncRNAs, miRNAs, and mRNAs in Clear Cell Renal Carcinoma.
    Lu W; Liu H; Zhang X; Guo Y; Liu L; Guo T; Qu L; Yang S; Li Z
    Comput Math Methods Med; 2022; 2022():8504441. PubMed ID: 35529267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
    Luo Q; Cui M; Deng Q; Liu J
    Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
    Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
    BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of competing endogenous RNA network and 3-mRNA signature predicting survival in papillary renal cell cancer.
    Zhu X; Tan J; Liang Z; Zhou M
    Medicine (Baltimore); 2019 Jul; 98(30):e16672. PubMed ID: 31348324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
    Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
    Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
    Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
    J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network.
    Gong K; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
    PLoS One; 2021; 16(6):e0252452. PubMed ID: 34101736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.